Please register or login to view the chart


Haematuria is the presence of blood or red blood cells in the urine.
Hematuria can be visible or non visible haematuria ( NVH )
Definition of microsopic haematuria varies between countries and guidelines One of the definitions is – three or greater red blood cells ( RBC’s ) per high powered field ( HPF ) on a properly collected urinary specimen in the absence of a benign cause The prevalence of microscopic haematuria is 0.9 % to 21 %- less than 1.5 % of these cases have a serious underlying pathology Some studies have shown a lower prevalence of microscopic haematuria in men Microscopic haematuria can be transient or persistent ( 3 or more consecutive samples ) Causes of transient MH include
vigorous exercise
sexual intercourse
mild trauma
menstrual contamination Microscopic haematuria can also be subdivided into
Symptomatic NVH
Asymptomatic NVH.
Upper and lower urinary tract-tumour , trauma , infection ( viral , bacterial , schistomsomiasis , TB )
Kidney-glomerular IgA nephropathy , thin basement membrane nephropathy , Alport syndrome , Posy-infectious GNephritis , mesangial proliferative GN , physical stress , local pain haematuria syndrome.
Kidney- non glomerular papillary necrosis , renal infarction , renal vein thrombosis , AV malformations / fistulas , cystic renal disease , medullary sponge kidney ,nutcracker syndromeUrinary bladder- radiation ,cystitis , stone.
prostate and urethra –Prostatitis , prostatic hyperplasia , BPH , diverticulum
malignancy-Renal cell carcinoma , TCC , SCC , urothelial cell carcinoma , prostate acinal adenocarcinoma, metastatic cancer
iatrogenic -recent endoscopic procedures ( e,g TURP ) , TRUS prostate , traumatic catherisation , radiation , indwelling ureteric stones, renal biopsies , EC shockwave therapy.

Non-visible haematuria –Investigating /managing microscopic haematuria is a clinical challenge Most cases of NVH are incidental findings Always take into account the risk factors for urothilial cancers ( see box ) NVH may have a benign cause in many particularly young women with symptoms and urinary feedings suggestive of a UTI Urine microscopy is not reliable in detecting NVH so it is not necessary to confirm NVH in laboratory Overall risk of bladder cancer is
24 % of patients with VH
4 % of patients with NVH NVH has only a 0.5 % positive predictive value for bladder cancer.
New symptomtic or asymptomatic NVH on 2 or 3 dipsticks > 1 +.
check BP U/E eGFR Check for proteinuria spot ACR or PCR MSU – exclude infection FBC if > 60 yr old.Investigations normal 
BP < 140/90 and eGFR > 60 and
No proteinuria ie PCR < 50 or ACR < 30.Cause not established
 Annual reassessment whilst haematuria persists -ie BP , eGFR , proteinuria Refer urology is patient develops visible haematuria or symptomatic NVH Refer to nephrologist if patient develops proteinuria
eGFR drops < 30 on 2 seperate ocassions
eGFR falls by > 5 over 1 year or 10 over 5 yrs. Investigations abnormal
BP > 140/90
eGFR < 60 or
Visible haematuria -Visible haematuria even when transient or symptomatic may indicate a serious underlying pathology which requires further investigation. Previously any painless visible haematuria of any age was referred by 2WkUSC guideline. However as the PPV of any haematuria was 0.99 % for men < 45 and 0.22 % for women < 45 yrs the 2 WUSC referral is recommended only for people with visible haematuria age > 45 without a UTI , or persisting recurring despite treatment of UTI ( NICE )
 Patient with VH are a higher risk group for urological malignancies than those with NVH ( BMJ Best Pract )

Visible haematuria is a presenting sign in more than 66 % of urological cancer
The sensitivity of visible haematuria in revealing mlignancy is significant.
Risk factors urothelial carcinoma 
( BMJ Best Practice )
 male sex age 35 yrs and over smoking exposure to benzene , aromatic aines , carcinogens , chemotherapy or high doses of analgesics h/o
irritative voiding symptoms
chronic UTI
indwelling urinary catheter
pelvic irradiation
British Association of Urological Surgeons – blood in urine
American Urological Association – what is hematuria
National Institute of Diabetes and Digestive and Kidney Diseases on Hematuria
Manchester Urology – with a video on haematuria
Edinburgh Renal Unit on Haematuria

  1. Camden CCG Haematuria pathway
  2. Macroscopic haematuria  A urological approach Melisa Yeoh et al Australian Family Physician Vol 42 , No 3 , March 2013
  3. The investigation of Hematuria Christian Bolenz et al Dtsch Arztebl Int 2018 Nov ; 115 ( 48 ) :801-807
  4. Evaluation and Management of Hematuria Masahito Jimbo Prim Care Clin Office pract 37 ( 2010 ) 461-472
  5. BMJ Best Practice Evaluation of visible hematuria
  6. Brighton and Sussex New Non-visible Haematuria Pathway



Related Charts:

A4 Medicine

Welcome to our newly updated website. A4Medicine is excited to announce that we continue to provide exceptional educational material to primary care healthcare professionals at an affordable rate. Please see our subscription plans for pricing. All plans come with a free 15-day trial. No money is taken from your payment method before the end of the free trial.

We are glad to offer all existing members/customers a 30% discount on yearly membership. If you have purchased The Visual Guidebook - you can claim the 30 % discount. These changes are applicable from 8th May 2021 and for any questions please write to